How is Research Addressing Toxicological Challenges?
Ongoing research is focused on improving the safety profile of CAR T cell therapies. This includes developing next-generation CARs with enhanced specificity and reduced off-target effects, as well as exploring combination therapies that could mitigate toxicities. Additionally, biomarkers for early detection of adverse reactions are being investigated to allow for preemptive interventions.
